Unlike humanized models utilizing peripheral blood mononuclear cells for immune cell reconstitution, the CD34+ model is much less prone to the development of GVHD, and no evidence of GVHD was noted throughout the duration of our tumor experiments. This evidence concerns the gene CD34 and neoplasm.